Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
54 Cards in this Set
- Front
- Back
|
Plots the energy loss of ionizing radiation during its travel through matter |
Bragg Peak |
|
|
Painful urination |
Dysuria |
|
|
Enlargement of a man's breast |
Gynecomastia |
|
|
Inability to sustain erection |
Impotence |
|
|
The area at the base of the urinary bladder, between the openings of the ureters and urethra. |
Trigone |
|
|
A sebaceous secretion in the folds of the skin, especially under a man's foreskin. |
Smegma |
|
|
#1 Histology of Prostate Cancer |
Adenocarcinoma |
|
|
Normal PSA |
<4 ng/ml Adjusted for age |
|
|
Prognostic factors of prostate cancer: |
Age, race, stage, grade, lymph node status, PSA level |
|
|
Risk factors for prostate cancer: |
Male Age Race Smoking Diet high in fat |
|
|
Symptoms of prostate cancer: |
Dysuria Difficulty starting urinary stream Decreased urinary stream Increased urinary frequency |
|
|
Patients with T1-T2 disease >10 year life expectancy |
Prostatectomy |
|
|
Dose for pelvic node treatment
(Prostate cancer) |
45-50 Gy
|
|
|
Dose for seminal vesicles |
54-56 Gy |
|
|
Dose for prostate |
72-80 Gy |
|
|
Higher dose per fraction |
Hypofractionation |
|
|
Post operative prostate palliation dose |
50-60 Gy |
|
|
Isotopes used to treat multiple metastatic bone lesions or skeletal sites |
Stronium 89 Samarium 153 |
|
|
CTV Margin for prostate cancer |
.55-1 cm |
|
|
OAR for prostate cancer |
Rectum, bladder, femur |
|
|
Order of CTV ITV PTV.... |
GTV CTV ITV PTV |
|
|
Whole Organ TD 5/5 Bladder |
65 Gy Contracture & Volume loss |
|
|
Whole Organ TD 5/5 Colon |
45 Gy Obstruction, perforation, ulceration, fistula
|
|
|
Whole Organ TD 5/5 Femoral head and neck |
52 Gy Necrosis |
|
|
Whole Organ TD 5/5 Rectum |
60 Gy Severe proctitis, necrosis, stenosis, fistula |
|
|
QUANTEC Rectum when treating prostate |
No more than 55% above 47 Gy |
|
|
QUANTEC Bladder when treating prostate |
No more than 55% above 47 Gy |
|
|
QUANTEC Femoral heads when treating prostate |
No more than 50% above 30 Gy |
|
|
OAR for prostate seed implant |
Rectum & Urethra |
|
|
Benefits of proton beam therapy for prostate cancer include: |
Peak dose at depth Rapid dose fall off beyond the peak |
|
|
4th most prevalent cancer in men |
Bladder cancer |
|
|
Risk factors of bladder cancer: |
Smoking and chronic bladder irritation |
|
|
Prognostic factors of bladder cancer: |
Extent of tumor, depth of muscle invasion, morphology, differentiation |
|
|
Lymphatics involved in bladder cancer: |
External iliac, internal iliac, presacral nodes |
|
|
Distant bladder metastasis: |
Lung, bone, liver |
|
|
Morphology for bladder cancer: |
Papillary Papillary infiltrating Solid infiltrating Non papillary non infiltrating in situ |
|
|
Symptoms of bladder cancer: |
Gross hematuria Dysuria Increased frequency and urgency in urination |
|
|
Bladder cancer doses Preop |
45-50Gy then surgery |
|
|
Bladder cancer doses After transurethral resection |
45-50 GY then boost to 65-70 Gy |
|
|
Sup and Inf bladder treatment borders: |
S1-S2 to obturator foramen |
|
|
Most common malignancy in men ages 15-34? |
Testicular cancer |
|
|
Testicular cancer presents as... |
Painless swelling or testicular mass |
|
|
Most common testicular cancer? |
Seminoma |
|
|
Prognostic factor of testicular cancer: |
Tumor stage |
|
|
Risk factors for testicular cancer: |
Cryptochidism Cancer history in one testicle |
|
|
One or more testicles dont distend |
Cryptochidism |
|
|
Lymph nodes involved in testicular cancer: |
Peri-aortic Ipsilateral pelvic nodes (common, internal, external iliacs) Retroperitoneum then mediastinal, supraclav nodes |
|
|
Stage 1 Testicular Cancer dose |
20 Gy in 10 fractions |
|
|
Stage 2 testicular cancer dose |
25 Gy in 10 fractions |
|
|
OAR for testicular cancer: |
Kidney, cord |
|
|
QUANTEC Kidney when treating testicular cancer |
No more than 50% of each kidney above 8 Gy If only 1 kidney, no more than 15% of kidney above 20 Gy |
|
|
Whole Organ TD 5/5 Whole kidney |
23 Gy Nephritis |
|
|
Acute side effects of testicular cancer |
Nausea Diarrhea Abdominal cramping Rectal discomfort Erythema Dry desquamation Moist desquamation Reduction in blood counts |
|
|
Chronic side effects of testicular cancer |
Secondary cancer Fibrosis Proctitis Telangiectasia Strictures Impotence Ulceration Necrosis Lymphedema of Legs |
